在药监数据库中导航重复:范围审查
Ronald Kiguba1, Gerald Isabirye2, Julius Mayengo2
1Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda kiguba@gmail.com.
BMJ open
|April 29, 2024
概括
药监数据库中的重复报告威胁着药物安全. 本次审查强调需要更好的重复预防,检测和管理策略,包括人工智能,以可靠地监测药物安全.
科学领域:
- 药监和药物安全 药监和药物安全
- 医疗保健数据库中的数据完整性
- 信息科学 信息科学 信息科学
背景情况:
- 药监数据库对于监测药物安全至关重要.
- 这些数据库中的数据重复会损害完整性和可靠性.
- 了解重复对于有效的药物安全监督至关重要.
研究的目的:
- 在全球范围内对药物监督数据库中的重复进行全面的范围审查.
- 识别和综合现有关于重复报告的原因,检测,预防和管理的知识.
主要方法:
- 采用了一种系统的范围审查方法.
- 在多个数据库 (PubMed,科学网等) 进行了广泛的文献搜索. 和灰色文学.
- 在数据提取和合成方面,遵循了乔安娜·布里格斯研究所的指导方针和PRISMA-ScR.
主要成果:
- 58项研究符合纳入标准,涉及重复的程度,预防,原因,检测,管理和影响.
- 确定的主要领域包括原因 (32篇论文),检测方法 (25篇论文) 和管理策略 (24篇论文).
- 人工智能,特别是自然语言处理,在提高除重复效率和精度方面表现有前途.
结论:
- 药监数据库的重复严重影响了风险评估和患者安全.
- 实施有效的重复预防,检测和管理对于提高数据可靠性至关重要.
- 建议始终使用唯一标识符并利用人工智能的进步,以尽量减少重复.
更多相关视频
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
9.7K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
相关概念视频
Pharmacovigilance
829
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
829
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
